China Journal of Chinese Materia Medica 2011 Issue 20 Survey on Xiaoke pill treating diabetes mellitus in small cities’ Chinese medicine hospital for post-marketing surveillance

Survey on Xiaoke pill treating diabetes mellitus in small cities’ Chinese medicine hospital for post-marketing surveillance
XIE Yanming1;ZHAO Yijun 2;LIU Huan 1;WANG Yongyan 1

..............page:2859-2861

jia qiang zhong cheng yao he li shi yong de jian yi
lv ai ping wang li ying

..............page:2762-2763

zhong yao shang shi hou lin chuang zai ping jia gong gong fu wu chan pin ping tai de gou jian
zhang de zheng chen fang ming xie yan ming

..............page:2891-2892

Sample size calculation in clinical post-marketing evaluation of traditional Chinese medicine
FU Yingkun;XIE Yanming

..............page:2904-2906

Interpretation of modified prescription for pharmacoeconomic analysis of New Zealand
WANG Xin1;2;SU Xia1;GAO Yan1;XIE Yanming3;WANG Yongyan3

..............page:2840-2843

ji ben yao wu mu lu zhi du yu zhong yao shang shi hou zai ping jia ji yu yu tiao zhan
wang yong yan xie yan ming zhao yu bin

..............page:2759-2760

Study of population pharmacokinetic model and parameter analyses for multiple components in Chinese matria medica formula
HE Fuyuan1;2;3;DENG Kaiwen4;LIU Wenglong1;2;3;SHI Jilian1;2;YANG Yantao1;3

..............page:2866-2870

Study on 10409 cases of post-marketing safety Danhong injection centralized monitoring of hospital
LI Xuelin1;TANG Jinfa1;MENG Fei1;LI Chunxiao1;XIE Yanming2

..............page:2783-2785

Clinical re-evaluation of effects of different treatments to prevent from phlebitis induced by Chansu injection
ZHAO Yubin1;2;HAO Zhe3;ZHANG Hongdan3;SHI Jian4;XIE Yanming5

..............page:2803-2806

shu xun

..............page:2785,2854,2873

Study on method on post-marketing traditonal Chinese medicine safety assessment
KOU Qiuai1;ZHAO Suping2;FENG Guoshuang3;XIE Yanming4

..............page:2771-2775

guo jia ke ji zhong da zhuan xiang zhong da xin yao chuang zhi zhong yao shang shi hou zai ping jia guan jian ji shu yan jiu (no.2009zx09502-030) jian jie

..............page:2757-2758

Study on building index system of risk assessment of post-marketing Chinese patent medicine based on AHP-fuzzy neural network
LI Yuanyuan;XIE Yanming;FU Yingkun

..............page:2828-2830

Process and key points of clinical literature evaluation of post-marketing traditional Chinese medicine
LIU Huan;XIE Yanming

..............page:2848-2850

Analysis of using Danhong injection to treatment coronary heart disease patient’s medicines based on real world HIS database
DU Jing1;YANG Wei2;YI Danhui1;XIE Yanming2;YANG Wei1;ZHUANG Yan3;CHEN Qian1

..............page:2821-2824

Exploring real world: analysis about Shenmai injection data extracted from hospital information system database in clinical practice
DU Jing1;YANG Wei2;YI Danhui1;XIE Yanming2;ZHUANG Yan3;YANG Wei1;CHEN Qian1

..............page:2813-2816

Study on clinical literature of Xiaoke pill’s adverse reaction based on experts’ evaluation
XIE Yanming;LIU Huan;WANG Yongyan

..............page:2855-2858

Comparative study on four kinds of assessment methods of post-marketing safety of Danhong injection
LI Xuelin1;TANG Jinfa1;MENG Fei1;LI Chunxiao1;XIE Yanming2

..............page:2786-2788

zhong guo zhong yao za zhi xian zhuang jian jie

..............page:2892

Design requirements for clinical trials on re-evaluation of safety and efficacy of post-marketed Chinese herbs
XIE Yanming;WEI Xu

..............page:2768-2770

Explore method about post-marketing safety re-evaluation of Chinese patent medicines based on HIS database in real world
YANG Wei1;XIE Yanming1;ZHUANG Yan2

..............page:2779-2782

Skin test: guide of post-marketed re-evaluation of clinical safety in traditional Chinese medicine injection
WEI Xu;XIE Yanming;WANG Yongyan

..............page:2877-2879

zhong cheng yao shang shi hou lin chuang zai ping jia : xun zheng yu chuang xin
zhang bo li

..............page:2761

Post-marketing re-evaluation of Kudiezi injection study on early treatment in patients with ischemic stroke
YE Xiaoqin1;WEI Xu2;XIE Yanming2;ZOU Yihuai3;ZHAO Xingquan4;HAN Jianhua5; WANG Xinzhi6;MA Yunzhi6;BI Qi7;XIE Qingfan8;ZHAO Jianjun9;CAO Xiaolan10; CHEN Hongxia11;WANG Shizhong12;YAN Rongmei13;HAN Zucheng14;YI Danhui15;WANG Yongyan2

..............page:2793-2795

Post-marketed re-evaluation of fleabane injection and Dengzhan Shengmai capsule study on treatment in patients with ischemic stroke
WEI Xu1;YE Xiaoqin2;XIE Yanming1;ZOU Yihuai3;ZHAO Xingquan4;HAN Jianhua5; WANG Xinzhi6;MA Yunzhi6;BI Qi7;XIE Qingfan8;ZHAO Jianjun9;CAO Xiaolan10; CHEN Hongxia11;WANG Shizhong12;YAN Rongmei13;HAN Zucheng14;YI Danhui15;WANG Yongyan1

..............page:2789-2792

Post-marketing re-evaluation about usage and dosage of Chinese medicine based on human population pharmacokinetics
JIANG Junjie;XIE Yanming

..............page:2811-2812

Clinical orientation and thought on several problems in post-marketed reassessment of traditional Chinese medicine
WANG Xin1;2;SU Xia1;YU Jie1;XIE Yanming3;WANG Yongyan3

..............page:2893-2897

Basic requirements on post-marketing clinical re-evaluation of Chinese medicine and phase Ⅳ clinical trials
XIE Yanming1;WANG Yanping1;TIAN Feng2;WANG Yongyan1

..............page:2764-2767

Construction and realization of real world integrated data warehouse from HIS on re-evaluation of post-maketing traditional Chinese medicine
ZHUANG Yan1;XIE Bangtie1;WENG Shengxin1;XIE Yanming2

..............page:2883-2887

Study on adverse drug reaction in Yuixngcao injection literatures
WANG Zhifei1;2;XIE Yanming1;WANG Yongyan1

..............page:2862-2865

Ethical consideration in several commonly used study design
WANG Xiuqin1;XIE Yanming2

..............page:2901-2903

Analysis of clinical use of Danhong injection based on hospital information system
CHEN Qian1;YI Danhui1;XIE Yanming2;YANG Wei2;YANG Wei1;ZHUANG Yan3;DU Jing1

..............page:2817-2820

zhong guo zhong yao za zhi tou gao xu zhi

..............page:2750

Application of nested case-control study on safe evaluation of post-marketing traditional Chinese medicine injection
XIAO Ying3;ZHAO Yubin1;2;XIE Yanming1

..............page:2796-2798

Application of Markov model in post-marketing pharmacoeconomic evaluation of traditional Chinese medicine
WANG Xin1;2;SU Xia1;SUN Wentao1;XIE Yanming3;WANG Yongyan3

..............page:2844-2847

Application of regular expression in extracting key information from Chinese medicine literatures about re-evaluation of post-marketing surveillance
WANG Zhifei1;2;XIE Yanming1;WANG yongyan1

..............page:2888-2890

Key elements of design about PPK of Chinese medicine after marketing
WANG Jiannong1;JIANG Junjie2;XIE Yanming2

..............page:2871-2873

Evaluation point of rational drug use of traditional Chinese medicine in market
GAO Rui1;SUN Mingyue2;XIE Yanming3

..............page:2807-2810

Research about re-evaluation of screening of traditonal Chinese medicine symptoms item of post-marketing medicine Xuezhikang
HE Wei1;XIE Yanming2;WANG Yongyan2

..............page:2898-2900

Strategy of individualized screening of allergens in serum of patients allergic to Shuanghuanglian injection based on RBL-2H3 mast cell model
XIAO Ying1;ZHAO Yubin2;3;XIE Yanming4

..............page:2799-2802

Pharmacovigilance of major parmaceutical innovation
XIANG Yongyang1;XIE Yanming2;YI Danhui3

..............page:2831-2835

Literature review of post-marketing clinical evaluation of Xiaoke pill
LIU Huan;XIE Yanming

..............page:2851-2854

Thought on several problems of post-marketing herbs clinical evaluation in special populations
ZHOU Ai;LIAN Fengmei

..............page:2776-2778

Phase 0 clinical trials and post-marketed re-evaluation of clinical safety in injection of traditional Chinese medicine
WEI Xu1;ZHANG Zhanjun2;XIE Yanming1;WANG Yongyan1

..............page:2874-2876

Guidance of FDA risk evaluation and mitigation strategy and enlightenment to drug risk management of post-marketing Chinese medicine
LI Yuanyuan;XIE Yanming

..............page:2825-2827

Designs and thoughts of real world integrated data warehouse from HIS on re-evaluation of post-maketing traditional Chinese medicine
ZHUANG Yan1;XIE Bangtie1;WENG Shengxin1;XIE Yanming2

..............page:2880-2882

Case study of Chinese medicine after listing of pharmacovigilance
XIANG Yongyang1;XIE Yanming2;YI Danhui1

..............page:2836-2839